DeepMed Research

BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Employees: -

Market Cap: -

Website: http://www.nebraska.edu

Clinical Trials

A Pharmacokinetic Evaluation of Levonorgestrel Implant and Antiretroviral Therapy

Phase 2

Completed

Conditions: HIV
Contraception

Interventions: Drug: Levonorgestrel
Drug: Nevirapine
Drug: Efavirenz

First Posted Date: 2013-02-12

Last Posted Date: 2023-09-01

Lead Sponsor: University of Nebraska

Target Recruit Count: 60

Registration Number: NCT01789879

Locations: 🇺🇬
Infectious Diseases Institute, Kampala, Uganda

Echo-guided Hemodynamic Management Strategy in Elderly Patients Undergoing Noncardiac Surgery

Not Applicable

Completed

Conditions: Ventricular Dysfunction, Left
Major Adverse Cardiac Events

Interventions: Procedure: EGHEM

First Posted Date: 2013-01-31

Last Posted Date: 2023-09-15

Lead Sponsor: University of Nebraska

Target Recruit Count: 97

Registration Number: NCT01780727

Locations: 🇺🇸
University of Nebraska Medical Center, Omaha, Nebraska, United States

Smokers' Response to Nicotine Dependence Genotyping

Not Applicable

Completed

Conditions: Nicotine Dependence
Cigarette Smoking

Interventions: Behavioral: Receipt of Genetic Results
Behavioral: No results given

First Posted Date: 2013-01-30

Last Posted Date: 2024-10-31

Lead Sponsor: University of Nebraska

Target Recruit Count: 24

Registration Number: NCT01780038

Locations: 🇺🇸
University of Nebraska Medical Center, Omaha, Nebraska, United States

Mathematical Modeling to Determine Basic Muscle Properties in the Failing Heart

Terminated

Conditions: Diastolic Heart Failure

First Posted Date: 2013-01-29

Last Posted Date: 2023-08-29

Lead Sponsor: University of Nebraska

Target Recruit Count: 37

Registration Number: NCT01778894

Locations: 🇺🇸
University of Nebraska Medical Center, Omaha, Nebraska, United States

Long-term Outcome of Laparoscopic Hiatal Hernia Repair With or Without Alloderm Mesh at a University Hospital

Completed

Conditions: Paraesophageal Hernia
Gastroesophageal Reflux Disease
Hiatal Hernia

First Posted Date: 2013-01-28

Last Posted Date: 2023-09-05

Lead Sponsor: University of Nebraska

Target Recruit Count: 69

Registration Number: NCT01776827

Locations: 🇺🇸
University of Nebraska Medical Center, Omaha, Nebraska, United States

Heart Failure Exercise And Resistance Training Camp (HEART Camp)

Not Applicable

Completed

Conditions: Heart Failure

Interventions: Behavioral: Heart Camp Group
Behavioral: Attention Control Group

First Posted Date: 2013-01-18

Last Posted Date: 2023-09-01

Lead Sponsor: University of Nebraska

Target Recruit Count: 42

Registration Number: NCT01771900

Locations: 🇺🇸
BryanLGH Heart Institute, Lincoln, Nebraska, United States

Platelet Inhibition in Patients With Systolic Heart Failure

Phase 4

Completed

Conditions: Systolic Heart Failure

Interventions: Drug: Prasugrel 10 mg daily x 2 weeks
Drug: Clopidogrel 75 mg daily x 2 weeks

First Posted Date: 2013-01-10

Last Posted Date: 2023-10-10

Lead Sponsor: University of Nebraska

Target Recruit Count: 30

Registration Number: NCT01765400

Locations: 🇺🇸
University of Nebaska Medical Center, Omaha, Nebraska, United States

Care4U: Self Management Intervention for Older Adult Caregivers

Not Applicable

Completed

Conditions: Cardiovascular Risk Factor

Interventions: Behavioral: Care4U

First Posted Date: 2013-01-09

Last Posted Date: 2023-09-05

Lead Sponsor: University of Nebraska

Target Recruit Count: 6

Registration Number: NCT01764399

Locations: 🇺🇸
Bryan Health, Lincoln, Nebraska, United States

Paclitaxel & Cyclophosphamide With or Without Trastuzumab Before Surgery in Treating Previously Untreated Breast Cancer

Phase 2

Active, not recruiting

Conditions: Estrogen Receptor Negative
Estrogen Receptor Positive
HER2/Neu Negative
HER2/Neu Positive
Invasive Breast Carcinoma
Progesterone Receptor Negative
Progesterone Receptor Positive
Stage IA Breast Cancer
Stage II Breast Cancer
Stage IIA Breast Cancer

Interventions: Drug: Cyclophosphamide
Drug: Doxorubicin Hydrochloride
Other: Laboratory Biomarker Analysis
Drug: Paclitaxel
Radiation: Radiation Therapy
Procedure: Therapeutic Conventional Surgery
Biological: Trastuzumab

First Posted Date: 2012-12-17

Last Posted Date: 2024-12-12

Lead Sponsor: University of Nebraska

Target Recruit Count: 92

Registration Number: NCT01750073

Locations: 🇺🇸
Nebraska Medicine-Bellevue, Bellevue, Nebraska, United States
🇺🇸
CHI Health Saint Francis, Grand Island, Nebraska, United States
🇺🇸
University of Nebraska Medical Center, Omaha, Nebraska, United States

and more 1 locations

Study of the Safety, Tolerability, and Bioactivity of Tocilizumab On Patients With Non-infectious UVEITIS: The STOP-UVEITIS Study

Phase 1

Conditions: Pan-uveitis
Posterior Uveitis
Intermediate Uveitis

Interventions: Drug: Tocilizumab

First Posted Date: 2012-10-30

Last Posted Date: 2017-04-28

Lead Sponsor: University of Nebraska

Target Recruit Count: 36

Registration Number: NCT01717170

Locations: 🇺🇸
Truhlsen Eye Institute, University Of Nebraska Medical Center, Omaha, Nebraska, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy